Bicara Therapeutics Inc (BCAX)
NASDAQ
The current BCAX market cap is 621.97M. The company's latest EPS is USD -0.9553 and P/E is -12.14.
Quarter End | Sep 2024 |
---|---|
USD ($) | |
Total Revenue | 0 |
Operating Income | -20.63M |
Net Income | -17.48M |
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Total Revenue | 0 |
Operating Income | -39.89M |
Net Income | -51.99M |
Quarter End | Sep 2024 |
---|---|
USD ($) | |
Total Assets | 524.17M |
Total Liabilities | 14.62M |
Total Equity | 509.56M |
Year End December 30 2023 | 2023 |
---|---|
USD ($) | |
Total Assets | 233.98M |
Total Liabilities | 15.47M |
Total Equity | -148.77M |
Market Cap | 621.97M |
Price to Earnings Ratio | -12.14 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 2.74 |
Price to Book Ratio | 2.89 |
Dividend Yield | - |
Shares Outstanding | 54.42M |
Average Volume (1 week) | 315.76k |
Average Volume (1 Month) | 365.76k |
52 Week Change | -56.46% |
52 Week High | 27.95 |
52 Week Low | 11.42 |
Spread (Intraday) | 5.57 (32.76%) |
Company Name | Bicara Therapeutics Inc |
Address |
corporation trust center wilmington, delaware 19801 |
Website | https://www.bicara.com |
Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.